Can the cHIS Score Predict ICU Mortality and Mechanical Ventilation in Critically Ill COVID-19 Patients?!
Preprint
- 28 April 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Objectives: Hyperinflammatory syndrome in COVID-19 (cHIS) is a severe immune dysregulation characterized by excessive cytokine release, contributing to adverse outcomes. The cHIS score has been proposed as a prognostic tool for identifying patients at risk of poor outcomes. Aim of this study was to validate the predictive accuracy of the cHIS score for mechanical ventilation requirements and ICU mortality in critically ill COVID-19 patients. Methods: This single-center, retrospective observational study included 85 critically ill COVID-19 patients admitted to the Intensive Care Unit of the University Clinical Center Tuzla between June 2020 and October 2020. Patients were stratified into groups on the basis of cHIS scores (< 3 and ≥3). cHIS score parameters, mechanical ventilation requirements and ICU mortality were analyzed. Logistic re-gression models and the area under the receiver operating characteristic (AUROC) curves were em-ployed to assess the predictive validity of the cHIS score. Results: Among 85 patients, 60% had cHIS scores ≥3. A cHIS score ≥3 was associated with in-creased risk of mechanical ventilation and ICU mortality. The sensitivity and specificity for predicting ICU mortality were 76% and 66%, respectively, while for mechanical ventilation, sensitivity was 73% and specificity 65%. Multivariate analysis confirmed the cHIS score as an independent predictor of both outcomes after adjusting for age and comorbidities. Conclusion: The cHIS score reliably predicts ICU mortality and mechanical ventilation in critically ill COVID-19 patients, supporting early risk stratification and targeted interventions to improve patient outcomes.Keywords
All Related Versions
This publication has 13 references indexed in Scilit:
- Estimating risk of mechanical ventilation and in-hospital mortality among adult COVID-19 patients admitted to Mass General Brigham: The VICE and DICE scoreseClinicalMedicine, 2021
- Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort studyThe Lancet Rheumatology, 2020
- Novel SARS-CoV-2 outbreak and COVID19 disease; a systemic review on the global pandemicGenes & Diseases, 2020
- COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort studyThe Lancet Rheumatology, 2020
- Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategiesInternational Journal of Antimicrobial Agents, 2020
- Cytokine Storms: Understanding COVID-19Immunity, 2020
- The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patientsInternational Immunopharmacology, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe Journal of Emergency Medicine, 2020
- Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophagesNature Reviews Immunology, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020